Structural Heart

This structural heart channel includes news, videos, podcasts and other content related to diagnosis and treatment of structural heart disease. Topics covered include heart valve repair and replacement, transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR), transcatheter tricuspid valve replacement (TTVR), left atrial appendage (LAA) occlusion, heart failure interventional device therapies, and closing holes in the heart using, including occlusion of atrial septal defects (ASDs), ventricular septal defects (VSDs) and patent foramen ovales (PFOs).

Leakage of the mitral valve due to degenerative prolapse is a common condition known as primary mitral regurgitation (MR).
News | Heart Valve Technology
Risk of Surgical Mitral Valve Repair for Primary Mitral Regurgitation

January 23, 2023 — Leakage of the mitral valve due to degenerative prolapse is a common condition known as primary ...

Home January 23, 2023
Home
Neovasc’s Innovative Reducer System will target the estimated $5 billion refractory angina market
News | Cardiovascular Business
Shockwave Medical Announces Agreement to Acquire Neovasc

January 19, 2023 — Shockwave Medical, Inc., a pioneer in the development of Intravascular Lithotripsy (IVL) to treat ...

Home January 19, 2023
Home
Neovasc’s Innovative Reducer System will target the estimated $5 billion refractory angina market
News | Structural Heart
Abbott Receives FDA Approval for Navitor TAVI System

January 19, 2023 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the company's latest ...

Home January 19, 2023
Home
Dean Kereiakes, MD, MSCAI
News | Embolic Protection Devices
Shockwave Intravascular Lithotripsy-assisted TMVR Shows Promise for Patients with Severe Stenosis and Regurgitation

January 11, 2023 — In recent years, transcatheter mitral valve replacement (TMVR) treatment and technology has evolved ...

Home January 11, 2023
Home
The ensemble delivery system of the Melody valve.
News | Pediatric Cardiology
New Pediatric Investigation Article Reviews the Potential of Transcatheter Pulmonary Valve Replacement for Congenital Heart Disorders

January 6, 2023 — Patients with congenital heart diseases often suffer from obstructions in the right ventricular ...

Home January 06, 2023
Home
DAIC Top 20 for 2022
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
DAIC's Top 20 from 2022

As 2022 comes to a close, the Diagnostic and Interventional Cardiology team takes a look at the year's most viewed ...

Home January 02, 2023
Home
The U.S. Food and Drug Administration (FDA) has given the approval to market to The Edwards Lifesciences PASCAL Precision Transcatheter Valve Repair System. 
News | Heart Valve Technology
FDA Grants Approval to Market of PASCAL Precision Transcatheter Valve Repair System

January 2, 2023 — The U.S. Food and Drug Administration (FDA) has given the approval to market to The Edwards ...

Home January 02, 2023
Home
Happy New Year from DAIC
News | Diagnostic and Interventional Cardiology DAIC
Happy New Year from DAIC

The DAIC team wishes you a very happy and safe New Year! 

Home January 01, 2023
Home
News | Congenital Heart
Smidt Heart Institute at Cedars-Sinai Welcomes Four New Specialists to Department of Cardiology

December 30, 2022 — The Smidt Heart Institute at Cedars-Sinai welcomes four new specialists to its Department of ...

Home December 30, 2022
Home
Joanna Chikwe, MD
News | Heart Valve Technology
Cedars-Sinai Designated as Mitral Valve Repair Reference Center

December 29, 2022 — The Smidt Heart Institute at Cedars-Sinai was named a Mitral Valve Repair Reference Center, a ...

Home December 29, 2022
Home
The AcQCross Qx system combines the dilator and needle needed to perform left-atrial appendage closure procedures, eliminating the need to swap equipment mid-surgery while crossing into the left side of the heart. (Pixabay)
News | Left Atrial Appendage (LAA) Occluders
Acutus Medical Achieves EU MDR Submission Milestone in Sale of Left-Heart Access Portfolio to Medtronic

December 22, 2022 — Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac ...

Home December 22, 2022
Home
Late-breaking clinical trials for the American College of Cardiology’s Annual Scientific Session Together with World Congress of Cardiology (ACC.23/WCC) have been announced.
Feature | ACC | By Melinda Taschetta-Millane
ACC 2023 Late-breaking Clinical Trials Announced

Late-breaking clinical trials for the American College of Cardiology’s Annual Scientific Session Together with World ...

Home December 20, 2022
Home
Edwards Lifesciences identified the top data releases from 2022 that contributed most to shaping awareness about the extent and impact of underdiagnosis and undertreatment of aortic stenosis (AS).
News | Heart Valve Technology
Edwards Identifies Top Data Releases of 2022 that Highlight the Impacts of Aortic Stenosis Undertreatment

December 14, 2022 — Edwards Lifesciences identified the top data releases from 2022 that contributed most to shaping ...

Home December 14, 2022
Home
Edwards Lifesciences Corporation announced that one-year results on patients treated in the single-arm, prospective, global, multi-center TRISCEND study of the company's EVOQUE transcatheter tricuspid valve replacement system demonstrated favorable safety, efficacy and quality-of-life outcomes.
News | Structural Heart
Edwards Announces One-year Data on Transfemoral Transcatheter Tricuspid Valve Replacement

December 13, 2022 — Edwards Lifesciences Corporation announced that one-year results on patients treated in the single ...

Home December 13, 2022
Home
Michael A. Mussallem
News | Cardiovascular Business
Edwards Lifesciences Announces CEO Succession Plan

December 12, 2022 —  Edwards Lifesciences Corporation announced that following regular succession planning discussions ...

Home December 12, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now